These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 23680109)
1. Mycoplasma hyopneumoniae: from disease to vaccine development. Simionatto S; Marchioro SB; Maes D; Dellagostin OA Vet Microbiol; 2013 Aug; 165(3-4):234-42. PubMed ID: 23680109 [TBL] [Abstract][Full Text] [Related]
2. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs. Park SJ; Seo HW; Park C; Chae C Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900 [TBL] [Abstract][Full Text] [Related]
3. Vaccination of piglets up to 1 week of age with a single-dose Mycoplasma hyopneumoniae vaccine induces protective immunity within 2 weeks against virulent challenge in the presence of maternally derived antibodies. Wilson S; Van Brussel L; Saunders G; Runnels P; Taylor L; Fredrickson D; Salt J Clin Vaccine Immunol; 2013 May; 20(5):720-4. PubMed ID: 23486417 [TBL] [Abstract][Full Text] [Related]
4. Acclimation strategies in gilts to control Mycoplasma hyopneumoniae infection. Garza-Moreno L; Segalés J; Pieters M; Romagosa A; Sibila M Vet Microbiol; 2018 Jun; 219():23-29. PubMed ID: 29778201 [TBL] [Abstract][Full Text] [Related]
5. A concise review of vaccines against Mycoplasma hyopneumoniae. Tao Y; Shu J; Chen J; Wu Y; He Y Res Vet Sci; 2019 Apr; 123():144-152. PubMed ID: 30665029 [TBL] [Abstract][Full Text] [Related]
6. Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs. Maes D; Boyen F; Devriendt B; Kuhnert P; Summerfield A; Haesebrouck F Vet Res; 2021 May; 52(1):67. PubMed ID: 33964969 [TBL] [Abstract][Full Text] [Related]
7. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions. Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621 [TBL] [Abstract][Full Text] [Related]
8. Blending of a conventional Mycoplasma hyopneumoniae vaccine with a positive marker: tracking of immunised pigs by peptide-specific antibodies raised to the marker component. Walders B; Raschke A; Neugebauer M; Geuther E; Bertling W; Reiser C; Buck A; Strich S; Hess J Res Vet Sci; 2005 Apr; 78(2):135-41. PubMed ID: 15563920 [TBL] [Abstract][Full Text] [Related]
9. Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies. Hillen S; von Berg S; Köhler K; Reinacher M; Willems H; Reiner G Prev Vet Med; 2014 Mar; 113(4):580-8. PubMed ID: 24485705 [TBL] [Abstract][Full Text] [Related]
10. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice. de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602 [TBL] [Abstract][Full Text] [Related]
11. Development of Mycoplasma hyopneumoniae Recombinant Vaccines. Marchioro SB; Simionatto S; Dellagostin O Methods Mol Biol; 2016; 1404():39-50. PubMed ID: 27076288 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs. Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953 [TBL] [Abstract][Full Text] [Related]
13. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus. Moreau IA; Miller GY; Bahnson PB Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Mycoplasma hyopneumoniae vaccination before and at weaning against experimental challenge infection in pigs. Arsenakis I; Panzavolta L; Michiels A; Del Pozo Sacristán R; Boyen F; Haesebrouck F; Maes D BMC Vet Res; 2016 Mar; 12():63. PubMed ID: 27025924 [TBL] [Abstract][Full Text] [Related]
15. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine. Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025 [TBL] [Abstract][Full Text] [Related]
16. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions. Jeong J; Park C; Choi K; Chae C Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046 [TBL] [Abstract][Full Text] [Related]
17. Control of Mycoplasma hyopneumoniae infections in pigs. Maes D; Segales J; Meyns T; Sibila M; Pieters M; Haesebrouck F Vet Microbiol; 2008 Jan; 126(4):297-309. PubMed ID: 17964089 [TBL] [Abstract][Full Text] [Related]
18. A field evaluation of two vaccines against Mycoplasma hyopneumoniae infection in pigs. Kristensen CS; Vinther J; Svensmark B; Bækbo P Acta Vet Scand; 2014 Apr; 56(1):24. PubMed ID: 24739629 [TBL] [Abstract][Full Text] [Related]
19. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia. Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775 [TBL] [Abstract][Full Text] [Related]
20. Application of a sIgA-ELISA method for differentiation of Mycoplasma hyopneumoniae infected from vaccinated pigs. Bai Y; Gan Y; Hua LZ; Nathues H; Yang H; Wei YN; Wu M; Shao GQ; Feng ZX Vet Microbiol; 2018 Sep; 223():86-92. PubMed ID: 30173757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]